Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Diagn Microbiol Infect Dis ; 109(3): 116324, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38733752

ABSTRACT

We aimed to determine the epidemiology and resistance patterns of Gram-negative bacteria, the risk factors and outcome of bloodstream infection (BSI). In all, 412 episodes in children who were hospitalized with the diagnosis of bacteremia were analyzed. The most common microorganisms were Klebsiella spp. (43.9%), Escherichia coli (13.5 %) and Acinetobacter spp. (10.6 %). Among isolates, 41.2 % were multidrug-resistant, 13.5 % were extensively drug-resistant and 0.4 % were pan-drug-resistant. Carbapenem resistance was revealed in 27.6 % of isolates. Carbapenem and colistin resistance increased over the years. The most common risk factors were the presence of a central-venous catheter and pediatric intensive care unit admission. Clinical response and infection-related mortality were significantly different in cases infected with carbapenem-resistant gram-negative (CRGN) vs carbapenem-susceptible gram-negative bacteria. The increase in multi-resistant Klebsiella spp. seems to be the biggest obstacles in fight against nosocomial infections. The increasing number of CRGN infections over the years affects both the clinical response and mortality rate of BSI.


Subject(s)
Anti-Bacterial Agents , Bacteremia , Gram-Negative Bacteria , Gram-Negative Bacterial Infections , Humans , Bacteremia/microbiology , Bacteremia/epidemiology , Bacteremia/mortality , Bacteremia/drug therapy , Risk Factors , Gram-Negative Bacterial Infections/epidemiology , Gram-Negative Bacterial Infections/microbiology , Gram-Negative Bacterial Infections/drug therapy , Gram-Negative Bacterial Infections/mortality , Child , Gram-Negative Bacteria/drug effects , Gram-Negative Bacteria/isolation & purification , Gram-Negative Bacteria/classification , Male , Child, Preschool , Female , Infant , Anti-Bacterial Agents/therapeutic use , Anti-Bacterial Agents/pharmacology , Drug Resistance, Multiple, Bacterial , Adolescent , Infant, Newborn , Treatment Outcome , Cross Infection/microbiology , Cross Infection/epidemiology , Cross Infection/mortality , Cross Infection/drug therapy , Microbial Sensitivity Tests , Retrospective Studies , Carbapenems/pharmacology , Carbapenems/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL